Caris Life Sciences, Inc. (CAI)
28.00
+1.87
(+7.16%)
USD |
NASDAQ |
Aug 25, 16:00
28.00
0.00 (0.00%)
After-Hours: 19:27
Caris Life Sciences Price to Book Value : 13.37 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 12.48 |
| August 21, 2026 | 12.55 |
| August 20, 2026 | 11.74 |
| August 19, 2026 | 10.87 |
| August 18, 2026 | 10.01 |
| August 17, 2026 | 10.33 |
| August 14, 2026 | 10.41 |
| August 13, 2026 | 10.59 |
| August 12, 2026 | 10.63 |
| August 11, 2026 | 11.05 |
| August 10, 2026 | 11.17 |
| August 07, 2026 | 10.86 |
| August 06, 2026 | 9.551 |
| August 05, 2026 | 7.856 |
| August 04, 2026 | 7.689 |
| August 03, 2026 | 7.794 |
| July 31, 2026 | 7.483 |
| July 30, 2026 | 7.684 |
| July 29, 2026 | 7.445 |
| July 28, 2026 | 7.445 |
| July 27, 2026 | 7.464 |
| July 24, 2026 | 7.412 |
| July 23, 2026 | 7.474 |
| July 22, 2026 | 7.345 |
| July 21, 2026 | 7.512 |
| Date | Value |
|---|---|
| July 20, 2026 | 7.431 |
| July 17, 2026 | 7.875 |
| July 16, 2026 | 7.87 |
| July 15, 2026 | 8.338 |
| July 14, 2026 | 8.094 |
| July 13, 2026 | 8.147 |
| July 10, 2026 | 8.114 |
| July 09, 2026 | 8.534 |
| July 08, 2026 | 8.271 |
| July 07, 2026 | 8.343 |
| July 06, 2026 | 8.505 |
| July 02, 2026 | 8.739 |
| July 01, 2026 | 8.954 |
| June 30, 2026 | 8.510 |
| June 29, 2026 | 8.725 |
| June 26, 2026 | 8.811 |
| June 25, 2026 | 8.906 |
| June 24, 2026 | 8.644 |
| June 23, 2026 | 8.382 |
| June 22, 2026 | 8.244 |
| June 18, 2026 | 8.796 |
| June 17, 2026 | 8.506 |
| June 16, 2026 | 8.563 |
| June 15, 2026 | 8.658 |
| June 12, 2026 | 8.558 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CareDx, Inc. | 6.146 |
| Myriad Genetics, Inc. | 1.008 |
| BioRestorative Therapies, Inc. | 1.853 |
| Natera, Inc. | 26.54 |
| Exagen, Inc. | 15.03 |
Price to Book Value Related Metrics
| PE Ratio | 75.21 |
| PS Ratio | 7.994 |
| Price to Free Cash Flow | 68.05 |
| Price | 28.00 |
| Earnings Yield | 1.33% |
| Market Cap | 7.912B |
| Operating PE Ratio | 51.61 |
| Normalized PE Ratio | 62.96 |